0001562180-16-003352.txt : 20161102 0001562180-16-003352.hdr.sgml : 20161102 20161102172510 ACCESSION NUMBER: 0001562180-16-003352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161031 FILED AS OF DATE: 20161102 DATE AS OF CHANGE: 20161102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TOTTEN POND ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 400 TOTTEN POND ROAD STREET 2: SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Egros Fabrice CENTRAL INDEX KEY: 0001597085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37708 FILM NUMBER: 161969098 MAIL ADDRESS: STREET 1: C/O SYNDAX PHARMACEUTICALS, INC. STREET 2: TOTTEN POND ROAD, SUITE 140 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-10-31 false 0001395937 Syndax Pharmaceuticals Inc SNDX 0001597085 Egros Fabrice C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110 WALTHAM MA 02451 true false false false Stock Option (Right to Buy) 11.81 2016-10-31 4 A false 8000.00 0.00 A 2026-10-31 Common Stock 8000.00 8000.00 D One hundred percent (100%) of the total number of shares underlying the option shall vest on October 31, 2017, subject to the reporting person's continuous service through the vesting date. /s/ Michael A. Metzger, Attorney-in-Fact 2016-11-02